193 related articles for article (PubMed ID: 11045145)
1. [Monitoring markers of bone turnover in multiple myeloma].
Spicka I; Spacek P; Hulejová H; Procházka B; Cieslar P; Chrz M; Válková V; Klener P
Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
[TBL] [Abstract][Full Text] [Related]
2. Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
Woitge HW; Pecherstorfer M; Horn E; Keck AV; Diel IJ; Bayer P; Ludwig H; Ziegler R; Seibel MJ
Br J Cancer; 2001 Feb; 84(3):344-51. PubMed ID: 11161399
[TBL] [Abstract][Full Text] [Related]
3. [Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].
Slabý J; Spicka I; Hulejová H; Spacek P; Cieslar P; Klener P
Cas Lek Cesk; 1997 Jan; 136(2):57-60. PubMed ID: 9147856
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
Corso A; Arcaini L; Mangiacavalli S; Astori C; Orlandi E; Lorenzi A; Passamonti F; Klersy C; Pascutto C; Canevari-Sciorati A; Lazzarino M
Haematologica; 2001 Apr; 86(4):394-8. PubMed ID: 11325645
[TBL] [Abstract][Full Text] [Related]
5. [Pyridinoline and deoxypyridinoline excretion in urine of healthy children--dependence on age].
Marowska J; Lukaszkiewicz J; Kobylińska M; Matusik H; Tałajko A; Lebiedowski M; Olszaniecka M; Madej M; Lorenc RS
Pol Tyg Lek; 1993 Nov; 48 Suppl 3():39-42. PubMed ID: 8309836
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
[TBL] [Abstract][Full Text] [Related]
7. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
[TBL] [Abstract][Full Text] [Related]
9. The renal clearance of free and conjugated pyridinium cross-links of collagen.
Colwell A; Eastell R
J Bone Miner Res; 1996 Dec; 11(12):1976-80. PubMed ID: 8970901
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors and markers of activity in multiple myeloma (results of the Cooperative Group for Diagnosis and Treatment of Multiple Myeloma)].
Spicka I; Cieslar P; Procházka B; Jirsa M; Chrz M; Gregora E; Klener P
Cas Lek Cesk; 2000 Apr; 139(7):208-12. PubMed ID: 10916207
[TBL] [Abstract][Full Text] [Related]
11. Changes in bone resorption during the menstrual cycle.
Chiu KM; Ju J; Mayes D; Bacchetti P; Weitz S; Arnaud CD
J Bone Miner Res; 1999 Apr; 14(4):609-15. PubMed ID: 10234583
[TBL] [Abstract][Full Text] [Related]
12. Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM).
Mejjad O; Le Loët X; Basuyau JP; Ménard JF; Jego P; Grisot C; Daragon A; Grosbois B; Euller-Ziegler L; Monconduit M
Eur J Haematol; 1996; 56(1-2):30-4. PubMed ID: 8599990
[TBL] [Abstract][Full Text] [Related]
13. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
Akesson K; Käkönen SM; Josefsson PO; Karlsson MK; Obrant KJ; Pettersson K
J Bone Miner Metab; 2005; 23(1):30-5. PubMed ID: 15616891
[TBL] [Abstract][Full Text] [Related]
14. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.
Toussirot E; Ricard-Blum S; Dumoulin G; Cedoz JP; Wendling D
Rheumatology (Oxford); 1999 Jan; 38(1):21-7. PubMed ID: 10334678
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the zinc nutritive status and biochemical markers of bone turnover in older European adults: the ZENITH study.
Hill T; Meunier N; Andriollo-Sanchez M; Ciarapica D; Hininger-Favier I; Polito A; O'Connor JM; Coudray C; Cashman KD
Eur J Clin Nutr; 2005 Nov; 59 Suppl 2():S73-8. PubMed ID: 16254587
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women.
Morgante G; La Marca A; Ditto A; Musacchio MC; Cavicchioli C; Lanzetta D; Petraglia F; De Leo V
Gynecol Endocrinol; 2001 Dec; 15(6):466-71. PubMed ID: 11826771
[TBL] [Abstract][Full Text] [Related]
18. Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases.
Walls J; Assiri A; Howell A; Rogers E; Ratcliffe WA; Eastell R; Bundred NJ
Br J Cancer; 1999 Jun; 80(8):1265-70. PubMed ID: 10376982
[TBL] [Abstract][Full Text] [Related]
19. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
